Effect of Low Dose NOACS (Rivaroxaban 2.5 mg Twice Daily) on Patients Who Underwent Complex Percutaneous Coronary Intervention

Efficacy and Safety and Mortality: Monitoring the patients on Rivaroxaban

EFFICACY AND SAFETY OUTCOMES OF RIVAROXABAN IN ACUTE DEEP VENOUS THROMBOSIS PATIENTS

Apixaban in Patients with Post-Myocardial Infarction Left Ventricular Thrombus: A Randomized Clinical Trial

Comparative study of safety and effectiveness of rivaroxaban and warfarin in patients with acute deep venous thrombosis

Safety and Mortality: Monitoring the Patients on Rivaroxaban

Rivaroxaban versus Warfarin in Treatment of Acute Lower Limb Deep Venous Thrombosis and its Affection on Quality of Life.

XANTUS-EL: A Real-World, Prospective, Observational Study of Patients Treated With Rivaroxaban For Stroke Prevention In Atrial Fibrillation In Eastern Europe, Middle East, Africa

Is rivaroxaban a safe and effective oral alternative to low-molecular-weight heparin in prophylaxis of portomesenteric and lower-limb deep-vein thrombosis after sleeve gastrectomy

Oral rivaroxaban for postoperative prophylaxis of venous thromboembolism after sleeve gastrectomy in patients with morbid obesity, is it safe: A prospective randomized clinical t